Published • loading... • Updated
India’s counterfeit drug crisis and the role of AI
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
India’s counterfeit drug crisis and the role of AI
India is facing a perilous rise in counterfeit high-value medicines, from cancer immunotherapies like Keytruda (pembrolizumab) to fast-growing weight-loss injections such as tirzepatide and semaglutide. These are not routine quality lapses—they are organised criminal operations that put patients at immediate risk. In today’s healthcare ecosystem, supply chain is no longer a support function—it is the engine of survival in the VUCA world. These …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
